Chemoembolization alone vs combined chemoembolization and hepatic arterial infusion chemotherapy in inoperable hepatocellular carcinoma patients

Table 1 Baseline clinical characteristics of patients enrolled n (%)

	Chemoembolization group (n = 39)	Chemoembolization + HAIC group (n = 45)	P-value
Age (yr)	59.69 ± 13.13	57.16 ± 10.34	0.325
Gender			0.832
Male	35 (89.7)	41 (91.1)
Female	4 (10.3)	4 (8.9)
Hepatitis condition			0.309
Hepatitis B	32 (82.1)	39 (86.7)
Hepatitis C	3 (7.7)	3 (6.7)
Hepatitis B + hepatitis C	1 (2.6)	3 (6.7)
Non-hepatitis	3 (7.7)	0
Grading of physical condition			0.393
PS = 0	18 (46.2)	24 (53.3)
PS = 1	21 (53.8)	21 (46.7)
Ascites			0.900
Yes	10 (25.6)	11 (24.4)
No	29 (82.4)	34 (75.6)
Liver function Child-Pugh			0.075
Grade A	36 (92.3)	41 (91.1)
Grade B	3 (7.7)	4 (8.9)
Diameter of tumor target lesion (cm)			0.347
≤ 10	19 (48.7)	29 (64.4)
> 10	20 (51.3)	16 (35.6)
Number of tumor			0.149
> 3	22 (56.4)	31 (68.9)
≤ 3	17 (43.6)	14 (31.1)
Blood vessel invasion			1.000
No	26 (66.7)	30 (66.7)
Yes	13 (33.3)	15 (33.3)
BCLC stage			0.860
Stage A	4 (10.3)	3 (6.7)
Stage B	9 (23.1)	15 (33.3)
Stage C	22 (56.4)	21 (44.1)
Relapse after surgical resection	4 (10.3)	6 (13.3)
Follow-up time, median (mo)	7.2 (1.3-15.2)	9.3 (3.8-14.6)	0.169